中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Mass spectrometry imaging: new eyes on natural products for drug research and development

文献类型:期刊论文

作者Hou, Jin-jun2,3; Zhang, Zi-jia2,3; Wu, Wen-yong1,3; He, Qing-qing3; Zhang, Teng-qian2,3; Liu, Ya-wen2,3; Wang, Zhao-jun2,3; Gao, Lei2,3; Long, Hua-li2,3; Lei, Min2,3
刊名ACTA PHARMACOLOGICA SINICA
出版日期2022-10-13
页码16
关键词natural product mass spectrometry imaging MALDI DESI molecular imaging ion mobility
ISSN号1671-4083
DOI10.1038/s41401-022-00990-8
通讯作者Wu, Wan-ying(wanyingwu@simm.ac.cn) ; Guo, De-an(daguo@simm.ac.cn)
英文摘要Natural products (NPs) and their structural analogs represent a major source of novel drug development for disease prevention and treatment. The development of new drugs from NPs includes two crucial aspects. One is the discovery of NPs from medicinal plants/microorganisms, and the other is the evaluation of the NPs in vivo at various physiological and pathological states. The heterogeneous spatial distribution of NPs in medicinal plants/microorganisms or in vivo can provide valuable information for drug development. However, few molecular imaging technologies can detect thousands of compounds simultaneously on a label-free basis. Over the last two decades, mass spectrometry imaging (MSI) methods have progressively improved and diversified, thereby allowing for the development of various applications of NPs in plants/microorganisms and in vivo NP research. Because MSI allows for the spatial mapping of the production and distribution of numerous molecules in situ without labeling, it provides a visualization tool for NP research. Therefore, we have focused this mini-review on summarizing the applications of MSI technology in discovering NPs from medicinal plants and evaluating NPs in preclinical studies from the perspective of new drug research and development (R&D). Additionally, we briefly reviewed the factors that should be carefully considered to obtain the desired MSI results. Finally, the future development of MSI in new drug R&D is proposed.
WOS关键词ION MOBILITY SPECTROMETRY ; ELECTROSPRAY-IONIZATION ; TISSUE-SECTIONS ; MATRIX ; BRAIN ; QUANTITATION ; METABOLITES ; PROTEINS ; DELIVERY ; HETEROGENEITY
资助项目STS (the Science and Technology Service Network Initiative of the Chinese Academy of Sciences) program[KFJ-STS-QYZD-2021-03-003] ; National Natural Science Foundation of China[81530095] ; National Natural Science Foundation of China[81673591] ; National Natural Science Foundation of China[81973455] ; National Natural Science Foundation of China[81973470] ; National Natural Science Foundation of China[82003939] ; National Natural Science Foundation of China[82003915] ; National Key Research and Development Program of China[2018YFC1707900] ; National Key Research and Development Program of China[2018YFC1707001]
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000867545400002
出版者NATURE PUBL GROUP
源URL[http://119.78.100.183/handle/2S10ELR8/302751]  
专题中国科学院上海药物研究所
通讯作者Wu, Wan-ying; Guo, De-an
作者单位1.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210029, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.Chinese Acad Sci, Natl Engn Res Ctr TCM Standardizat Technol, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Hou, Jin-jun,Zhang, Zi-jia,Wu, Wen-yong,et al. Mass spectrometry imaging: new eyes on natural products for drug research and development[J]. ACTA PHARMACOLOGICA SINICA,2022:16.
APA Hou, Jin-jun.,Zhang, Zi-jia.,Wu, Wen-yong.,He, Qing-qing.,Zhang, Teng-qian.,...&Guo, De-an.(2022).Mass spectrometry imaging: new eyes on natural products for drug research and development.ACTA PHARMACOLOGICA SINICA,16.
MLA Hou, Jin-jun,et al."Mass spectrometry imaging: new eyes on natural products for drug research and development".ACTA PHARMACOLOGICA SINICA (2022):16.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。